NASDAQ:BSTC - BioSpecifics Technologies Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $88.50
  • Forecasted Upside: -0.03 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$88.53
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New BioSpecifics Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BSTC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BSTC

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$88.50
▼ -0.03% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for BioSpecifics Technologies in the last 3 months. The average price target is $88.50, with a high forecast of $88.50 and a low forecast of $88.50. The average price target represents a -0.03% upside from the last price of $88.53.
Hold
The current consensus among 1 investment analysts is to hold stock in BioSpecifics Technologies. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/13/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/11/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/10/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/9/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/7/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/5/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/4/2020

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/20/2020HC WainwrightDowngradeBuy ➝ Neutral$100.00 ➝ $88.50Low
i
Rating by Ram Selvaraju at HC Wainwright
7/7/2020HC WainwrightBoost Price TargetBuy$90.00 ➝ $100.00High
i
Rating by Ram Selvaraju at HC Wainwright
6/16/2020HC WainwrightReiterated RatingBuy$90.00High
i
Rating by Ram Selvaraju at HC Wainwright
11/20/2019HC WainwrightReiterated RatingBuy$90.00Low
i
Rating by Ram Selvaraju at HC Wainwright
10/11/2019HC WainwrightSet Price TargetBuy$90.00Medium
i
Rating by Ram Selvaraju at HC Wainwright
8/12/2019HC WainwrightReiterated RatingBuy$85.00 ➝ $90.00High
i
Rating by Ram Selvaraju at HC Wainwright
3/19/2019HC WainwrightSet Price TargetBuy$85.00Medium
i
Rating by Ram Selvaraju at HC Wainwright
1/25/2019HC WainwrightReiterated RatingBuy$81.00Low
i
Rating by Ram Selvaraju at HC Wainwright
11/8/2018HC WainwrightReiterated RatingBuy ➝ Buy$81.00N/A
i
Rating by Ram Selvaraju at HC Wainwright
11/1/2018HC WainwrightSet Price TargetBuy$72.00Low
i
Rating by Ram Selvaraju at HC Wainwright
8/10/2018HC WainwrightSet Price TargetBuy$65.00Low
i
Rating by Ram Selvaraju at HC Wainwright
7/5/2018HC WainwrightReiterated RatingBuy$65.00High
i
Rating by Ram Selvaraju at HC Wainwright
5/10/2018HC WainwrightSet Price TargetBuy$65.00High
i
Rating by Ram Selvaraju at HC Wainwright
4/30/2018HC WainwrightSet Price TargetBuy$65.00High
i
Rating by Ram Selvaraju at HC Wainwright
3/13/2018HC WainwrightReiterated RatingBuy$65.00Low
i
Rating by Ram Selvaraju at HC Wainwright
1/1/2018HC WainwrightReiterated RatingBuyLow
i
Rating by Ram Selvaraju at HC Wainwright
12/26/2017HC WainwrightReiterated RatingBuyLow
i
Rating by Ram Selvaraju at HC Wainwright
12/11/2017HC WainwrightReiterated RatingBuyLow
i
Rating by R. Selvaraju at HC Wainwright
11/13/2017HC WainwrightReiterated RatingBuy ➝ Buy$72.00 ➝ $65.00N/A
i
Rating by Ram Selvaraju at HC Wainwright
8/10/2017HC WainwrightSet Price TargetBuy$72.00High
i
10/6/2016HC WainwrightReiterated RatingBuy$60.00N/A
i
8/10/2016Rodman & RenshawReiterated RatingBuy$60.00N/A
i
Rating by Ram Selvaraju at Rodman & Renshaw
6/13/2016Rodman & RenshawReiterated RatingBuyN/A
i
Rating by Ram Selvaraju at Rodman & Renshaw
6/2/2016Rodman & RenshawReiterated RatingBuyN/A
i
Rating by Ram Selvaraju at Rodman & Renshaw
3/8/2016HC WainwrightReiterated RatingBuyN/A
i
Rating by Y. Chen at HC Wainwright
3/8/2016Rodman & RenshawInitiated CoverageBuy$60.00N/A
i
(Data available from 12/4/2015 forward)
BioSpecifics Technologies logo
BioSpecifics Technologies Corp., a biopharmaceutical company, develops an injectable collagenase clostridium histolyticum for various indications in the United States and internationally. The company offers injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease under the XIAFLEX and Xiapex brands. It also provides injectable collagenase to treat frozen shoulder, cellulite, canine lipoma, lateral hip fat, plantar fibromatosis, human lipoma, and uterine fibroids. The company has a development and license agreement with Endo Global Ventures. BioSpecifics Technologies Corp. was founded in 1957 and is headquartered in Wilmington, Delaware.
Read More

Today's Range

Now: $88.53
$88.53
$88.53

50 Day Range

MA: $85.59
$60.55
$88.85

52 Week Range

Now: $88.53
$42.00
$89.15

Volume

N/A

Average Volume

104,936 shs

Market Capitalization

$649.81 million

P/E Ratio

37.51

Dividend Yield

N/A

Beta

0.24